Neuronity cures neurological disorders by promoting immunity of the central nervous system.
Neuronity Therapeutics has raised $780K in total funding. The most recent round was Grant. The last funding was announced in July 2023.
Neuronity Therapeutics's investors include Michael J. Fox Foundation.
Neuronity Therapeutics is headquartered in Mansfield, United States.
Neuronity cures neurological disorders by promoting immunity of the central nervous system.
Neuronity Therapeutics is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Neuronity Therapeutics — Funding & Investors." VCBacked, July 3, 2023, https://www.vcbacked.co/company/neuronity-therapeutics. Accessed August 14, 2026.
VCBacked. (2023). Neuronity Therapeutics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/neuronity-therapeutics
{{cite web |title=Neuronity Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/neuronity-therapeutics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated